Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett

Showing results (711-720 of 1,050) with videos related to

Pageof 105
Sort By:
Rheumatology (Oxford, England)|September 16, 2021
Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATEMaria Antonietta D'Agostino, Georg Schett, Alejandra López-Rdz, et al.
Scientific Reports|August 21, 2021
Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse modelMarie-Lisa Hülser, Yubin Luo, Klaus Frommer, et al.
Journal of Cell Science|September 17, 2009
Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesisCordula Surmann-Schmitt, Nathalie Widmann, Uwe Dietz, et al.
Annals of the Rheumatic Diseases|May 8, 2017
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatmentYun Zhang, Ruifang Liang, Chih-Wei Chen, et al.
Lancet (London, England)|February 10, 2020
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trialChristopher T Ritchlin, Arthur Kavanaugh, Joseph F Merola, et al.
The Journal of Clinical Investigation|January 29, 2020
TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosisClara Dees, Sebastian Pötter, Yun Zhang, et al.
Arthritis and Rheumatism|February 16, 2010
Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritisStephan Blüml, Nikolaus B Binder, Birgit Niederreiter, et al.
The Journal of Clinical Investigation|April 7, 2015
12/15-Lipoxygenase-mediated enzymatic lipid oxidation regulates DC maturation and functionTobias Rothe, Florian Gruber, Stefan Uderhardt, et al.
BMC Health Services Research|December 2, 2022
At-home blood self-sampling in rheumatology: a qualitative study with patients and health care professionalsFelix Muehlensiepen, Susann May, Joshua Zarbl, et al.
The Journal of Experimental Medicine|March 23, 2005
CD44 is a determinant of inflammatory bone lossSilvia Hayer, Günter Steiner, Birgit Görtz, et al.
Pageof 105

Showing results (711-720 of 1,050) with videos related to

Sort By:
Pageof 105
Rheumatology (Oxford, England)|September 16, 2021
Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATEMaria Antonietta D'Agostino, Georg Schett, Alejandra López-Rdz, et al.
Scientific Reports|August 21, 2021
Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse modelMarie-Lisa Hülser, Yubin Luo, Klaus Frommer, et al.
Journal of Cell Science|September 17, 2009
Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesisCordula Surmann-Schmitt, Nathalie Widmann, Uwe Dietz, et al.
Annals of the Rheumatic Diseases|May 8, 2017
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatmentYun Zhang, Ruifang Liang, Chih-Wei Chen, et al.
Lancet (London, England)|February 10, 2020
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trialChristopher T Ritchlin, Arthur Kavanaugh, Joseph F Merola, et al.
The Journal of Clinical Investigation|January 29, 2020
TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosisClara Dees, Sebastian Pötter, Yun Zhang, et al.
Arthritis and Rheumatism|February 16, 2010
Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritisStephan Blüml, Nikolaus B Binder, Birgit Niederreiter, et al.
The Journal of Clinical Investigation|April 7, 2015
12/15-Lipoxygenase-mediated enzymatic lipid oxidation regulates DC maturation and functionTobias Rothe, Florian Gruber, Stefan Uderhardt, et al.
BMC Health Services Research|December 2, 2022
At-home blood self-sampling in rheumatology: a qualitative study with patients and health care professionalsFelix Muehlensiepen, Susann May, Joshua Zarbl, et al.
The Journal of Experimental Medicine|March 23, 2005
CD44 is a determinant of inflammatory bone lossSilvia Hayer, Günter Steiner, Birgit Görtz, et al.
Pageof 105